About the Millenia Hope Clinical Studies

• Successful in infected patients compared to failure rates of up to 75% with standard therapies.
• Very infrequent, transient, mild efforts in a few individuals.
• Initial Pediatric formulation unsuccessful, reformulation in process

Trial done by Dr. Francesco du Chaira Clinic Ospedale di Anchilo

• Initial proof of concept (equivalent Phase 1 safety & efficacy in malaria patient)
• Mozambique 1998

Trials done by Prof. Albert Same-Ekobo, Member of WHO-TDR Steering Committee, Coordinator of the central Africa Network for Malaria Monitoring, V.P. of Cameroon’s Roll Back Malaria Committee and a Professor of Parasitology at the University of Younde.

• To establish treatments dosage levels and confirm efficacy in malaria patients (equivalent Phase lla) – 1998 Cameroon,
• To confirm efficacy in a larger group of malaria patients (equivalent to Phase llb) – 2001 Cameroon and 2003 Cameroon.

Trials done by Max Koula, National coordinator of the Republic of Central Africa’s (RCA) anti-malarial program, Dr. Etienne Fernand Gbagba, Chief of emergency Medical Services at community Hospital in Bangui, RCA and Dr. Wilfred Nambei, an immunologist, Head of Parasitology and Microbiology at the University of Bangui, RCA.

• To further confirm efficacy in a large group of malaria patients (equivalent to Phase lll) - RCA 2004 - 2 trials

Trials done by Dr.Soriba Cisse of Millenia Hope at a private clinic

• To further confirm efficacy in a large group of malaria patients (equivalent to Phase lll) - Guinea Conakry - 2005